Low BMI Means Lower Risk Of Diabetes, Even In Non-Obese People
According to a study, lower BMI (body mass index) is consistently linked to decreased type II diabetes risk, amongst people having a varied family medical history, genetic risk aspects, and weight. The new study was led by Manuel Rivas from Stanford University and was published in the journal PLOS Medicine. The weight-loss interventions have shown to be beneficial for reducing the peril of type II diabetes in pre-diabetic and high-risk people but have not been well-analyzed in people at low peril of diabetes. In the recent study, scientists studied the link amid BMI, diabetes history in the family, and genetic risk factors impacting BMI or type II diabetes. Researchers used data on 287,394 unrelated people of British ancestry in the U.K. Biobank during 2006–2010 between the 40–69 Years age.
The study revealed that nearly 5% of the volunteers had an identification of type II diabetes and diabetes occurrence was confirmed to be linked to higher BMI, family history of type II disease, and genetic peril factors. Additionally, a 1 kg/m2 BMI lessening was interrelated with a 1.37 fold decline in type II diabetes amongst non-obese people having a BMI of below 25 and no family record of diabetes, similar to the effect of BMI lessening in obese people having a family history. The authors said, “These findings indicated that everyone can considerably decrease their type II diabetes peril through weight loss.”
On a related note, recently a study showed that people with type II diabetes—who have flu—are more inclined to be hospitalized. The peril for hospitalization due to pandemic influenza is high for patients having type II diabetes compared to those without type II diabetes, as per to a study. The study findings were published in the Journal of Internal Medicine. Paz L.D. Ruiz, from the NIPH (Norwegian Institute of Public Health) in Oslo, along with colleagues utilized linked individual-level statistics from many national registers for all Norwegian people aged 30 Years and older to evaluate influenza-related difficulties amongst patients having type II diabetes (from 2009 to 2013).